Csiky B, Simon G
Department of Medicine, University of Minnesota, Minneapolis 55417, USA.
Am J Physiol. 1997 Feb;272(2 Pt 2):H648-56. doi: 10.1152/ajpheart.1997.272.2.H648.
We tested, in the early stage of angiotensin II (ANG II)-induced hypertension, whether sympathectomy prevented the autopotentiation of vasoconstrictor responses by ANG II and, in the chronic, established phase of hypertension, whether the antihypertensive effect of sympathectomy, if any, was related to the prevention of structural vascular changes. Neonatally and sham-sympathectomized male Sprague-Dawley rats received 100 or 200 ng x kg(-1) x min(-1) ANG II intraperitoneally for 7-10 days or 200 ng x kg(-1) x min(-1) ANG II subcutaneously for 4 wk. Sham-treated sympathectomized and sham-sympathectomized rats were controls. Vasoconstrictor responses to ANG II, norepinephrine (NE), arginine vasopressin, and periarterial nerve stimulation were measured in the mesentery of rats, and thereafter, in the chronically treated rats, mesenteric resistance arteries were fixed in situ for morphometric measurements. In ANG II-treated sham-sympathectomized rats: 1) tail systolic blood pressure was unchanged after 7-10 days and increased by 23 mmHg at 4 wk (P < 0.001); 2) vasoconstrictor responses were selectively increased to ANG II (autopotentiation; P = 0.026) and nerve stimulation (P = 0.031) at 7-10 days and nonselectively increased to all stimuli at 4 wk (P < 0.05 to P < 0.01); and 3) after 4 wk, the wall-to-lumen ratio of resistance arteries was increased (P < 0.02). In ANG II-treated sympathectomized rats, there were no changes in systolic blood pressure or vasoconstrictor responses at either 7-10 days or 4 wk, but structural vascular changes developed to the same extent as in sham-sympathectomized ANG II-treated rats. Autopotentiation of vasoconstrictor responses appears to be due to an interaction between ANG II and the sympathetic nervous system, because it is prevented by sympathectomy. The dissociation of function and structure in the chronic stage of ANG II administration to sympathectomized rats suggests that structural vascular changes by themselves are insufficient to cause hypertension, but increased vascular reactivity or vasoconstrictor input is also needed.
我们在血管紧张素II(ANG II)诱导的高血压早期阶段,测试了交感神经切除术是否能阻止ANG II引起的血管收缩反应的自身增强作用;在高血压的慢性、已确立阶段,测试了交感神经切除术的降压作用(如果有的话)是否与预防血管结构改变有关。新生期接受假交感神经切除术和交感神经切除术的雄性Sprague-Dawley大鼠,分别腹腔注射100或200 ng·kg⁻¹·min⁻¹的ANG II,持续7 - 10天,或皮下注射200 ng·kg⁻¹·min⁻¹的ANG II,持续4周。接受假处理的交感神经切除大鼠和假交感神经切除大鼠作为对照。在大鼠肠系膜中测量对ANG II、去甲肾上腺素(NE)、精氨酸加压素和动脉周围神经刺激的血管收缩反应,此后,对长期处理的大鼠,将肠系膜阻力动脉原位固定以进行形态学测量。在接受ANG II处理的假交感神经切除大鼠中:1)7 - 10天后尾收缩压无变化,4周时升高23 mmHg(P < 0.001);2)7 - 10天时对ANG II的血管收缩反应选择性增加(自身增强;P = 0.026),对神经刺激的反应也增加(P = 0.031),4周时对所有刺激的反应非选择性增加(P < 0.05至P < 0.01);3)4周后,阻力动脉的壁腔比增加(P < 0.02)。在接受ANG II处理的交感神经切除大鼠中,7 - 10天或4周时收缩压或血管收缩反应均无变化,但血管结构改变的程度与接受ANG II处理的假交感神经切除大鼠相同。血管收缩反应的自身增强作用似乎是由于ANG II与交感神经系统之间的相互作用,因为交感神经切除术可阻止这种作用。对交感神经切除大鼠给予ANG II的慢性阶段中功能与结构的分离表明,血管结构改变本身不足以导致高血压,还需要增加血管反应性或血管收缩输入。